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Abstract
In Pseudomonas aeruginosa, conversion to the mucoid phenotype marks the onset of an irreversible state of the infection in
Cystic Fibrosis (CF) patients. The main pathway for mucoid conversion is mutagenesis of the mucA gene, frequently due to
21 bp deletions in a simple sequence repeat (SSR) of 5 Gs (G
5-SSR426). We have recently observed that this mucA mutation
is particularly accentuated in Mismatch Repair System (MRS)-deficient cells grown in vitro. Interestingly, previous reports
have shown a high prevalence of hypermutable MRS-deficient strains occurring naturally in CF chronic lung infections. Here,
we used mucA as a forward mutation model to systematically evaluate the role of G
5-SSR426 in conversion to mucoidy in a
MRS-deficient background, with this being the first analysis combining SSR-dependent localized hypermutability and the
acquisition of a particular virulence/persistence trait in P. aeruginosa. In this study, mucA alleles were engineered with
different contents of G:C SSRs, and tested for their effect on the mucoid conversion frequency and mucA mutational spectra
in a mutS-deficient strain of P. aeruginosa. Importantly, deletion of G
5-SSR426 severely reduced the emergence frequency of
mucoid variants, with no preferential site of mutagenesis within mucA. Moreover, although mutagenesis in mucA was not
totally removed, this was no longer the main pathway for mucoid conversion, suggesting that G
5-SSR426 biased mutations
towards mucA. Mutagenesis in mucA was restored by the addition of a new SSR (C
6-SSR431), and even synergistically
increased when G
5-SSR426 and C
6-SSR431 were present simultaneously, with the mucA mutations being restricted to 21b p
deletions within any of both G:C SSRs. These results confirm a critical role for G
5-SSR426 enhancing the mutagenic process of
mucA in MRS-deficient cells, and shed light on another mechanism, the SSR- localized hypermutability, contributing to
mucoid conversion in P. aeruginosa.
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Introduction
Mutation is an essential feature of pathogenic prokaryotes, being
involved in the generation of genetic variability and the acquisition
of adaptive phenotypes. In fact, many virulence traits important in
host colonization and sudden environmental changes (i.e., antimi-
crobial therapy, host immune response), are acquired by mutagenic
events. Thus, factors which regulate mutagenesis may play critical
roles in the pathogen’s establishment and evolution within the host.
Occasionally, increasing the mutation rate may facilitate the
adaptation to different stimuli in bacterial populations [1]. Reports
of this phenomenon involve different mechanisms, which include
the presence of naturally-occurring stable mutators (i.e., DNA
Repair-deficient strains), inducible or transient hypermutators (i.e.,
induction of error-prone DNA polymerases), and hypermutable
genetic sequences (i.e., DNA simple sequence repeats [SSRs]).
Regarding this last mechanism, SSRs are defined as tandem
repetitions of shortmotives and arelargely accounted foras a source
of genetic variability [2,3] through the generally accepted slipped-
strand mispairing mechanism [2,4]. In fact, there is extensive
literatureinvolvingSSRsinpathogenesisofseveralbacterialspecies,
frequently playing crucial roles in the antigenic- or phase-variation
that occur at contingency loci (reviewed in [2]).
Pseudomonas aeruginosa is an opportunistic pathogen that chron-
ically infects the lungs and airways of Cystic Fibrosis (CF) patients,
which in order to persist in the CF lung, undergoes a genetic
adaptation based on mutagenic events [5]. However, although the
participation of stable hypermutators in this process has been
investigated [6,7], there are no reports about the role of SSR-
localized hypermutability in the acquisition of phenotypes that
allow its long-term persistence. Among these phenotypes,
conversion to mucoidy (exopolysaccharide alginate-overproduc-
tion) is one of the most important virulence traits in P. aeruginosa,
since it confers protection against the host immune response [8,9],
reactive oxygen intermediates [10], and pulmonary clearance [11].
In fact, the emergence of the mucoid phenotype in the CF lung
marks the onset of an irreversible state of the infection and poor
prognosis for the patient [12].
More than one possible pathway leading to alginate overpro-
duction has been described [13], i.e. positive regulation by rpoN
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[15–17]. However, the most frequent pathway that leads to the
mucoid phenotype is the acquisition of loss-of-function mutations
in a single gene, mucA, which encodes for a negative regulator of
alginate production [18]. Studies of CF mucoid isolates have
shown that mucA harbored loss-of-function mutations in more than
85% of isolates [11,16,19]. Similarly, work in our laboratory and
by other researchers has shown mucA to be the main target for
mutagenesis in mucoid variants obtained in vitro [20,21]. These
studies found that for several types of mutations, one of the most
represented was the 21 deletion in a monomeric SSR of five Gs
(G
5-SSR426) located at position 426 from the mucA start codon
(widely known as mucA22 allele) [11,16,19–22].
In a previous recent work, we determined in vitro that two factors
involved in the regulation of the overall mutation rate, MutS (a
main component of the Mismatch Repair System) and Pol IV (the
error-prone DNA polymerase encoded by dinB), were essential to
establish mucA as the main target for mutagenesis in mucoid
conversion, with these two factors having a prominent role in the
generation of the mucA22 allele [21]. Questions that still remained
unsolved are: 1) why was there such a high percentage of mucoid
isolates in which mutations in mucA were found? 2) what is special
about mucA that makes it the main pathway to mucoid conversion
(thus leaving a secondary role to other genes whose inactivation
are also known to induce mucoidy, such as mucB and mucD)? 3)
does mucA contain a hotspot for mutagenesis? 4) what is the role of
G
5-SSR426 in this phenomenon? Concerning this last question,
since no study to date has evaluated the role of any SSR in P.
aeruginosa, little is known about their relevance in this mutagenic
adaptive processes. In an attempt to shed light on this, we designed
and constructed mucA alleles with different SSR compositions by
site directed mutagenesis, and then analyzed the emergence
frequency of mucoid variants and the spectrum of mucA mutations
in strains carrying the different mucA alleles. Assays were
performed using a DNA Mismatch Repair System (MRS)-
defective mutS strain for several reasons: 1) the low spontaneous
rate of mucoid conversion and the low yield of mucA22 alleles in
nonmutator strains do not allow an accurate analysis in this
experimental system [21]; 2) MRS-deficient strains most directly
reflect the mutagenesis (in frequency and nature) of the ongoing
DNA synthesis [23]; 3) they provide a larger yield of mucoid
variants [21]; 4) this yield is enriched in mucA22 alleles [21];.
Furthermore, previous studies have reported a large proportion of
P. aeruginosa hypermutator MRS-deficient strains occurring
naturally in CF chronic infections [7], which has been proposed
to catalyze the genetic adaptation for persistence in the CF lung
environment [6]. This leads to the idea that the coexistence of
SSRs and MRS deficiency might be a typical phenomenon in the
CF lung.
In this work, we show that in a MRS-deficient background, G
5-
SSR426 was an essential hotspot biasing mutations to mucA thereby
contributing, together with stable hypermutability, in the deter-
mination of mucA as the main pathway for mucoid conversion in P.
aeruginosa.
Results
The Presence of SSRs in mucA Increases the Yield of
Mucoid Variants in P. aeruginosa
As mentioned above, mutations in the mucA gene are known to
be the major cause of mucoid conversion in P. aeruginosa [18].
Previous mucA sequence analyzes of mucoid isolates, obtained from
CF patients as well as under laboratory conditions, showed that
they mostly harbored the mucA22 allele (a 21 bp deletion in a
homopolymeric G:C SSR here referred to as G
5-SSR426)
[11,16,19–22]. In order to determine the role of G
5-SSR426 in
mucA mutagenesis leading to P. aeruginosa mucoid conversion, we
constructed strain MPA-T1 with its mucA sequence lacking G
5-
SSR426 (mucAT1 allele) (Figure 1). This strain was generated in a
mutS deficient background in order to increase the yield of mucoid
variants, and also because this background allows the direct
observation of replicative errors without interference by the MRS.
Previous studies have established that mucoidy, a phenotype
that is almost exclusively observed in chronic infections, could be
reproducibly obtained in vitro from the effluent run-offs of
continuous flow-cultured biofilms [20,21]. Based on these
antecedents, bacteria were grown in continuous cultured biofilms,
with the effluents run-off being plated in order to score for mucoid
variants (easily distinguishable as ‘‘mucous droplet-like’’ colonies).
In addition, the mucoid phenotype of each variant was confirmed
by the carbazole method which showed a$3 fold increase in
alginate production respect to the parental strain.
Then, the mucoid variant emergence frequencies of strains
MPA-T1 and its parental MPA were compared. As shown in
Figures 2A and 2B, the emergence frequency of mucoid variants
suffered a significant 5.3 fold decrease (p,0.05, t-test) in strain
MPA-T1 (0.0960.05%) respect to strain MPA which carried the
wild type mucA (0.4860.20%), providing evidence that under the
conditions used, G
5-SSR426 was involved in the mucoid
conversion process.
To test whether the elevated frequency of mucoid conversion
was an exclusive feature of G
5-SSR426, and to examine whether a
SSR (different from G
5-SSR426) was able to restore the level of
generation of mucoid variants lost in MPA-T1, we tested strain
MPA-T2, which lacked G
5-SSR426 in mucA, but carried a new
stretch of 6 Cs (C
6-SSR431) located immediately after the region
previously occupied by G
5-SSR426 (Figure 1). It is worth noting
that the hypothetical deletion of one C in C
6-SSR431 generates the
Figure 1. Site directed mutagenesis on the mucA gene. A
fragment of the P. aeruginosa mucA gene where the site directed
mutagenesis was performed is shown. Base changes (bold face) were
designed in order to maintain the amino acidic sequence unaltered
(shown below), and codons were chosen that are commonly used by P.
aeruginosa. The premature stop codon generated by a hypothetical
21 bp deletion between positions 426 and 436 of mucA is underlined.
Wild type mucA allele from MPA strain with G
5SSR426 is highlighted in
yellow. The mucAT1 allele from strain MPA-T1 was generated by
replacing G-to-A at 426 and G-to-T at 429, thus eliminating G
5SSR426.
The mucAT2 allele from strain MPA-T2 was generated by replacing G-to-
A at 426 and G-to-T at 429 (eliminating G
5SSR426), and G-to-C at 432 and
435 to generate C
6SSR431 (highlighted in blue). The mucAT3 allele from
strain MPA-T3 was generated by replacing G-to-C at 432 and 435 to
generate C
6SSR431 (highlighted in blue), and maintaining G
5SSR426
(highlighted in yellow) unaltered.
doi:10.1371/journal.pone.0008203.g001
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important, in order to try to avoid as much as possible an altered
emergence frequency of mucoid variants due to differential
selection instead of differential mutagenesis between mucA alleles.
As shown in Figures 2A and 2B, the emergence frequency of
mucoid variants in strain MPA-T2 (0.7860.38%) showed an
increase of 1.6-fold respect to MPA, which although not
statistically significant (p.0.05, t-test) implied a 7.1-fold increase
respect to MPA-T1. This result not only supports the previous
observation that the presence of a SSR such as G
5-SSR426 was
determinant in the generation of mucoid variants, but also
indicates that this function could be replaced by another SSR
different from the wild type G
5-SSR426.
In order to test the simultaneous effect of G
5-SSR426 and C
6-
SSR431 on the emergence frequency of mucoid variants, a new
strain was generated (MPA-T3) which carried both SSRs
(G
5C
6SSR426)( mucA-T3 allele) (Figure 1). In the same way, a
hypothetical 21 deletion in G
5C
6SSR426 generates the same
premature stop codon at 440 as the mucA22 allele.
Strikingly, strain MPA-T3 showed a significant increase in the
emergence frequency of mucoid variants of more than one order of
magnitude (8.9661.00%) respect to strains MPA or MPA-T2
(p,0.05, t-test) (Figure 2A and 2B). This result clearly indicates that
the combination of both SSRs had a synergistic incremental effect
on the yield of mucoid variants, as in the case of a larger single SSR.
To check that no variation in the global mutagenesis of the cell
was acquired during strain constructions, the four strains (MPA,
MPA-T1, MPA-T2 and MPA-T3) were subjected to the Rf-
resistance test, which is a widely known assay to determine the
overall mutagenic state of the cell [24]. The frequencies of Rf-
resistant cells presented the expected values for mutS-deficient
hypermutator strains, which were similar in the four strains
(4.4-5610
26 cells). Furthermore, in order to verify that the basal
alginate production was not altered by the different mucA allele
replacements, alginate production was measured in the four strains
by the carbazole method [25]. Basal alginate production did not
vary among strains MPA, MPA-T1, MPA-T2 and MPA-T3 (150–
200 mg per ml of growth culture), which confirms that the
modifications engineered in mucA did not produce a constitutive
overproduction of alginate.
SSRs Constitute Hotspots for Mutagenesis in mucA
In a recent study [21], we showed that the overall hypermu-
tability generated by inactivation of the MRS gene mutS produced
Figure 2. Role of SSRs in P. aeruginosa mucoid conversion. (A) Mucoid variants, visualized as mucous droplet-like colonies emerging from MPA,
MPA-T1, MPA-T2 and MPA-T3 strains plated onto MMA plates. (B) Relative emergence of mucoid variants obtained from MPA-T1, MPA-T2 and MPA-T3
strains. The values were compared to those obtained for the MPA strain. *Values for MPA-T1 and MPA-T3 were significantly different (p,0.05, as
determined by the t-test) from that of MPA. (C) Spectrum of mucA mutations observed in mucoid variants obtained from MPA, MPA-T1, MPA-T2 and
MPA-T3 strains. Bars indicate the observed percentage for each kind of mutation of the total number of mucoid clones analyzed in each strain (total
clones analyzed: MPA, 11; MPA-T1, 13; MPA-T2, 13; and MPA-T3, 15). Bars in yellow indicate those mucoid variants that occurred in the absence of
mucA alterations. The observed mutations included base substitutions (gray) and 21 bp deletions in mononucleotide G:C SSRs (blue).
doi:10.1371/journal.pone.0008203.g002
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decrease in the variability of mutations in mucA. For this mutS
strain, mutagenesis in mucA was clearly the leading pathway for
mucoid conversion, and interestingly, the most represented
mutation was the 21 deletion in G
5-SSR426 generating the
mucA22 allele [21]. In order to determine if the carriage of different
mucA alleles affects the prevalence of the mucA conversion pathway,
and to analyze the spectra of mutations of mucA alleles harboring
different SSRs, the mucA gene of mucoid variants obtained from
the four strains, MPA, MPA-T1, MPA-T2 and MPA-T3, was
PCR amplified and subjected to automated direct sequence
analysis.
Regarding the fraction of the mucoid isolates that harbored
mutations in mucA in this study, MPA showed mutations in mucA
for 73% of the mucoid isolates (Figure 2C). Analysis of mucA
mutations demonstrated that 75% corresponded to the mucA22
allele, with the remaining 25% being represented by C-to-T
transitions (Table 1 and Figure 2C). Both observations about the
prevalence and spectrum of mucA mutations are in agreement with
our previous results [21], with this being the spectrum typically
observed in MRS deficient strains [26,27].
Elimination of G
5-SSR426 in MPA-T1 reduced the prevalence
of mucA mutations among the mucoid isolates to 31% (Figure 2C).
Notably, this result, together with the decrease in the emergence of
mucoid variants in MPA-T1 (Figure 2A and 2B), suggest that after
the elimination of G
5-SSR426, mutagenesis of mucA was no longer
the major pathway of mucoid conversion. The spectrum analysis
of mucA also showed that no mutation had occurred in the region
previously occupied by G
5-SSR426. Instead, an increase in the
variability of mutations was observed, in which four isolates (80%)
harbored different C-to-T and G-to-A transitions, with one isolate
(20%) having a deletion of one C in a stretch of four Cs located
between 362 and 365 (C
4SSR362) of the coding region of mucA,
thus generating a premature stop codon at 385 (Table 1 and
Figure 2C). This result demonstrates that in strain MPA-T1,
mutagenesis in mucA was not biased to any particular DNA motif,
indicating that there were no distinguishable hotspots for
mutagenesis within the mucA-T1 allele. Furthermore, this obser-
vation suggests that in strain MPA, the emergence of mucoid
variants might not be due to the effect of scattered mutagenesis
along the mucA gene and further selection, but could greatly
depend on the presence of G
5-SSR426 biasing mutations, thereby
constituting a real hotspot for mutagenesis in a MRS-deficient
background.
Notably in strain MPA-T2, which carried C
6-SSR431,t h e
proportion of mucoid variants that harbored mutations in mucA
increased to 93% (Figure 2C), thus restoring and even surpassing
the proportion observed for the MPA wild type allele. Interestingly,
this strain showed a drastic reduction in the spectrum of mucA
mutations, in which 100% were represented by a 21 bp deletion
within C
6-SSR431 (Table 1 and Figure 2C). Therefore, it is evident
that this SSR (6 bp long) has a stronger biasing capacity respect to
G
5-SSR426 (5 bp long), which could be logically explained due to its
larger size. However, as it has been previously observed in E. coli
[28], the possibility that G:C SSRs may have different levels of
mutagenesis depending on their orientations respect to the
replication fork should also be considered (see Discussion).
In the case of MPA-T3, which carried G
5C
6-SSR426, 100% of
the mucoid isolates harbored mutations in mucA, with these
mutations being 21 bp deletions and showing a distribution
between both SSRs of 67% for C
6-SSR431 and 33% for G
5-
SSR426 (Table 1 and Figure 2C). This distribution of mutations is
also consistent with the differential capacity of each SSR to bias
mutations (Figure 2C), and could explain the previous observation
of the higher mucoid emergence frequency for strain MPA-T2,
although this was not statistically significant compared with MPA
(Figure 2B). Furthermore, spectra observed in strains MPA-T2
and MPA-T3 clearly suggest that no other kind of alterations or
rearrangements are occurring in the SSRs apart from the slipped-
strand mispairing mechanism.
Taken together, these results indicate that G
5-SSR426 is a
hotspot, which, based on its length, is able to bias but not restrict
mutations towards the mucA gene. Thus, G
5-SSR426 constitutes a
major element, without which, mucA ceases to be the leading
pathway for conversion to mucoidy in MRS-deficient P. aeruginosa.
Most of the Loss-of-Function Mutations Occur in the
Periplasmic Coding Region of mucA, Independently of
the SSR Content
We next performed a survey of different studies reporting
mutations in the mucA gene from P. aeruginosa CF isolates, in order to
analyze the way in which mucA is mutated. Four different studies
[11,16,22,29], along with own unpublished data, showed that the
great majority of mucoid isolates obtained from CF are due to
frameshifts or base substitutions along the coding sequence of mucA
(Table 2). Among these mutations, different C-to-T transitions and
21 bp deletion frameshifts were the most represented, with most of
these 21 bp deletions occurring in G
5-SSR426, thus generating the
mucA22 allele (Table 2). As we observed for the mucoid variants
obtained from MPA, MPA-T1, MPA-T2 and MPA-T3 (Table 1),
and also for the clinical mucoid isolates, independent of the kind of
mutation (either base substitution or 21 bp frameshift), in every
Table 1. Mutations in the mucA gene of mucoid isolates from
strains MPA, MPA-T1, MPA-T2 and MPA-T3.
Strain and mucA mutation
a Stop
b Number of isolates
MPA
DG at 426 TGA at 440 6
CRT at 424 TAG at 424 1
CRT at 436 TAG at 436 1
None none 3
MPA-T1
DC at 362 TGA at 385 1
GRA at 249 TGA at 247 1
CRT at 367 TAG at 367 1
CRT at 424 TAG at 424 1
CRT at 505 TAG at 505 1
none none 9
MPA-T2
DC at 431 TGA at 440 12
none none 1
MPA-T3
DG at 426 TGA at 440 5
DC at 431 TGA at 440 10
aDG at 426 corresponds to a 21 bp deletion within G
5SSR426; DCa t3 6 2
corresponds to a 21 bp deletion within a mononucleotide SSR of four Cs from
362 to 365 (C
4SSR362); DC at 431 corresponds to a 21 bp deletion within
C
6SSR431. ‘‘None’’ refers to conversion to mucoidy occurring in the absence of
mucA mutations. The nature of these non-mucA alterations leading to a
mucoid phenotype was not investigated in this work.
bStop codon produced at the site of the mutation by substitutions or placed in
frame by frameshift mutations.
doi:10.1371/journal.pone.0008203.t001
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premature stop codon, thus providing a truncated version of MucA.
It is important to point out that MucA is an anti-sigma factor
located at the inner membrane of the cell, which has an N-terminal
cytoplasmic region (MucA7–57), a transmembrane domain
(MucA84–104) and a periplasmic C-terminal domain (MucA113–170)
[30,31]. Based on this protein domain structure, we then analyzed if
the stop mutations were clustered at any particular region of mucA.
With few variations among studies, stop mutations were concen-
trated almost exclusively in the periplasmic coding region of mucA
(84–100%), in a proportion that was significantly higher than the
few remaining stop mutations observed in the transmembrane
(0–13%) (p,0.001, Z-test), and the cytoplasmic (0–3%) (p,0.001,
Z-test) coding regions of mucA. Our own previous results with
mucoid variants obtained from laboratory conditions showed a
similar distribution of mutations along the mucA gene [21].
We next wondered whether the G
5-SSR426 capacity of biasing
mutations was a determinant factor of the region at which most
mutations were found. As shown above, strains MPA, MPA-T2 and
MPA-T3 (with their SSRs in the periplasmic coding region of mucA)
had all the alterations affecting this domain (Table 1). In the case of
strain MPA-T1, although the prevalence of mucA mutations was
greatly decreased and demonstrated no defined hotspot for
mutagenesis, most of the mutations found in mucA (80%) also
affected the periplasmic coding region of the gene (Table 1). This
domaindistributionofmutationswasnot significantlydifferentfrom
that observed in clinical isolates (p=0.989, Z-test), which indicates
that the presence of G
5-SSR426 does not play a major role in the
selectionofthefunctionaldomainofMucAinwhichmutationsarise
or are selected. Thus, other sequence properties of mucA and/or
selection forces on the MucA domain that is mutated may prevail
over the effect of any SSR producing a bias on mutagenesis.
In order to determine other properties in the sequence of mucA,
which might lead to differential mutagenesis between domains, we
further sought for all the possible positions at which premature
stop codons could be generated by C-to-T transitions (which is the
other large group of mutations observed in mucA). Thus, we
surveyed all the CAG and CAA codons (which encode for
Glutamine) and CGA (which encodes for Arginine), and their
respective distributions in the mucA gene. Interestingly, MucA
possesses 14 Glutamine residues, of which 12 (86%) are located
within the periplasmic region, and the remaining 2 (14%) in the
cytoplasmic region. No CGA codon for Arginine was observed in
the whole coding sequence of mucA. If it is assumed that each of the
14 Glutamine codons possesses an equal or similar probability of
changing to a stop codon, then the observation mentioned above
suggests that this distributive bias of Glutamine codons towards the
periplasmic coding region of mucA, might contribute to the higher
prevalence of non-sense mutations within this domain. Neverthe-
less, since MucA is highly regulated by proteolysis in response to
certain types of stress [31–36], this analysis cannot rule out the
possibility of selection pressures favoring periplasmic over non-
periplasmic truncated versions of MucA.
G
5-SSR426 Is Conserved in Most of the P. aeruginosa
Strains, but Not in Other Pseudomonad Related Species
Since MucA is an anti-sigma factor highly conserved among
several bacterial species (also known as RseA), we next scored for
G
5-SSR426 or a similar SSR in the mucA gene of other
Pseudomonad related species [37], some of which are also
known to have the possibility of acquiring a mucoid phenotype
[38,39]. The survey of P. fluorescens Pf-5, P. putida KT2440, P.
stutzeri A1501, P. syringae 1448A and DC3000, P. entomophila L48,
and P. mendocina ymp, revealed that although their identity scores
respect to P. aeruginosa mucA sequence are high ($72), none of
these species harbored G
5-SSR426 or any other G:C SSR
exceeding 4 bp in their mucA genes, which indicates that G
5-
SSR426 might be exclusive for P. aeruginosa. Related to this, we
then analyzed if G
5-SSR426 was conserved intraspecifically by
comparing the mucA sequence of several P. aeruginosa strains. This
survey was performed on an own collection of 38 CF strains (not
shown), one environmental strain Hex1T [40], and strains PAO1,
PA14, LESB58 and PA7, whose genome sequence data are
available online [37]. A comparative analysis showed that the
scores of the identities of the mucA gene of the different strains
respect to the mucA sequence of PAO1were $98. Thus, it was not
surprising to find that G
5-SSR426 was conserved in the mucA
sequences of almost every strain of P. aeruginosa.H o w e v e r ,G
5-
SSR426 was not present in strain PA7. Instead, PA7 showed an
intriguing feature: a new SSR, also of five Gs located at 354 (G
5-
SSR354) in place of the SSR of four Gs observed in every other
strain of P. aeruginosa. Curiously, in strain PA7 a 21 bp deletion
within G
5-SSR354 generates the same premature stop codon at
440 as that produced by a 21 bp deletion within G
5-SSR426 of
the other P. aeruginosa strains. Thus, the presence of G
5-SSR426
and/or G
5-SSR354,which showed to be absent in every other
Pseudomonad species here analyzed, seems to be an intraspecif-
ically highly conserved feature, which is so far unique for P.
aeruginosa.
Discussion
In P. aeruginosa, mutagenesis in the mucA gene is the main
pathway for conversion to mucoidy, an alginate-overproducing
Table 2. Classification of mucA mutations reported in different studies for P. aeruginosa CF isolates.
Location
Analyzed
isolatesa Kinds of mutations in mucA (%)
21b pi nG 5SSR430/Total
21 bp deletions (%) Reference
Transi-tions Transver-sions 21 bp deletions Other indels
b
USA 41 34 9 32 25 67 [11]
Australia 22 50 0 29 21 57 [29]
Germany 14 41 0 53 6 88 [22]
Scandinavia 148 46 1 33 20 80 [16]
Argentina 24 29 8 63 0 67 Unpublished
aFor each study, only the isolates for which the mucA mutations were reported were considered in the analysis.
bInsertion or deletion mutations different from 21 bp deletions.
doi:10.1371/journal.pone.0008203.t002
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of CF patients. Mucoid conversion dramatically increases the
resistance of the bacteria to pulmonary clearance mechanisms,
and marks the transition to an irreversible state of the infection
[12,13]. In a previous recent work, we show that the mutagenic
activity of the error-prone DNA polymerase Pol IV and the MRS
loss-of-function, major factors involved in the inducible and stable
hypermutability of the cell respectively, are key determinants
targeting mucA for mucoid conversion in vitro [21]. Under a MutS
deficiency and Pol IV proficiency background, the spectrum of
mutation in mucA is dominated by frameshift mutations in a
particular mononucleotide G:C SSR of five Gs (here denominated
as G
5SSR426), suggesting that instability of this SSR could be
another main determinant which leads to mucoid conversion and
makes mucA a very attractive model to study the involvement of the
mutagenic mechanisms in P. aeruginosa adaptation.
Thus, in the present study, we attempted to elucidate the role of
G
5SSR426 in the process of conversion to mucoidy in a mutS
deficient strain, which is to our knowledge the first systematic
study of the mutagenic role of a SSR in P. aeruginosa. We used the
mucA gene and allelic variants of mucA, engineered to contain
different G:C SSR compositions (Figure 1), as a forward system for
the detection of mutations that confer mucoidy. Importantly,
although the system designed in this work for P. aeruginosa lacks the
benefit of selection, it shares the advantage of other chromosomal
forward systems used in other bacterial species for the detection of
broad mutational spectra [41,42] over reversion systems, in which
the number of sites and kinds of mutations that can produce the
revertant phenotype are quite limited [43–48].
As mentioned above, mutagenesis in mucA constitutes the main
pathway for conversion to mucoidy, although other possible
pathways that convergently lead to alginate overproduction have
also been described [14,15,17]. Therefore, mucA mutations have
previously been considered to be ‘‘pathoadaptive’’, since their
occurrence and the subsequent action of natural selection shift
bacterial adaptationto the pathologic lung environment [49]. In the
present study, we demonstrate in a MRS-deficient strain that
mutagenesis inmucAis notscattered, butis infact biasedtowards the
21 bp deletion in G
5SSR426. Related to this, we show that the
elimination of G
5SSR426 not only significantly reduced the
mutation frequency in mucA (Figures 2A and 2B), but also expanded
the spectrum of mutations with no apparent hotspot (Table 1 and
Figure 2C). Most importantly, in the absence of G
5SSR426, mucA
was no longer the major pathway for mucoid conversion, providing
strong evidence that G
5SSR426 makes mucA more prone to
mutation. Interestingly, analysis of the coding sequences of the
mucB and mucD genes (whose inactivation also lead to mucoid
conversion) revealed that whereas mucD lacks mononucleotide G:C
SSRs exceeding 4 bp, mucB possesses a SSR of 5 Cs. However, a
recent study on a large collection of CF isolates which reported
several mutations for the mucB gene showed that none of these
occurred within this C-SSR [16]. Thisobservation results intriguing
since this C-SSR and G
5SSR426 in mucA which could be considered
comparable SSRs, are actually not. This allows the speculation that
not only the preferential mucA mutagenesis may have a major
selective component to it, but also that the C-SSR in mucB does not
represent a hotspot for mutagenesis within the gene, as it has been
observed for G
5SSR426 in mucA.
Furthermore, taking into account the results on mucA mutagen-
esis obtained in our previous work, it seems that G
5SSR426 is a hot
substrate for both Pol IV-induced replication errors and correction
by mismatch machinery [21]. Thus, our model of mucA
mutagenesis demonstrates the combined action of the three
mechanisms known to increase cellular mutability: inducible
hypermutability, stable hypermutability and SSR-localized hyper-
mutability. Also, previous studies have reported a high proportion
of P. aeruginosa hypermutator MRS-deficient strains naturally
occurring in CF pulmonary chronic infections [7], with SOS
induction of Pol IV being recently described in P. aeruginosa
[50,51]. All these observations suggest that stressful environmental
lung conditions might be propitious for mucoid conversion via
MutS, Pol IV and G
5SSR426-dependent mutagenesis. In this
context, it is important to remember that approximately 85% of
the P. aeruginosa mucoid clinical isolates harbor mutations in mucA,
and that for 25–40% of these mutations, 21 bp deletions are
found in G
5SSR426 [11,16,19,22]. In this way, given that longer
SSRs (as experimentally confirmed with mucA alleles carrying
C
6SSR431 or G
5C
6SSR426) may confer a level of hypermutability
that could turn mucA the exclusive genetic pathway to mucoid
conversion, we conclude that not only the existence, but also the
length of G
5SSR426, is a major determinant of the mucA-dependent
mucoid conversion process.
Regarding the different level of mutagenesis observed between
G
5SSR426 and C
6SSR431, it should be considered that not only
their length, but also their orientations respect to the replication
fork may influence the mutagenesis outcome. In fact, it has been
observed in E. coli, that frameshift mutagenesis on G:C SSRs
displays an asymmetry during leading and lagging-strand
replication [28]. Accordingly, a strand bias has also been reported
for the mutagenic activity of Pol IV [52], which has been shown to
be the main DNA polymerase involved in mutagenesis of
G
5SSR426 in vitro [21]. In this sense, further studies are necessary
to elucidate the effect of strand biased mutagenesis in P. aeruginosa.
Furthermore, it results disturbing that the increase in the
mutation frequency observed due to C
6SSR431- and G
5C
6SSR426-
localized mutagenesis, was produced in strains that were already
stable hypermutators. As these hypermutator strains have been
frequently reported for CF patients [7], our results indicate that
under such a hypermutable background, genes involved in
virulence which possess large G:C SSRs should deserve a special
concern.
On the other hand, the survey of different studies which
reported the mutations in the mucA gene observed in P. aeruginosa
CF isolates, showed that the great majority of the mutations in
mucA generate premature stop codons at its periplasmic domain
coding region, with most of these mutations being 21 bp deletions
within G
5SSR426 or different C-to-T transitions (Table 2). This
way of periplasmic mutagenesis has also been observed in mucoid
variants emerged in vitro, from hypermutator and non-mutator
strains of P. aeruginosa [20,21]. Here we observed that elimination
of G
5SSR426 did not change the functional domain at which most
mucA mutations were found (Table 1). This means that other
sequence features of mucA and/or selective forces favoring
periplasmic mutated versions of mucA might play a role in the
distribution of mutations observed along the gene. As a possible
explanation, we observed that the periplasmic, but not the
transmembrane/cytoplasmic domains of MucA, is rich in
Glutamine, with this being the substrate for the generation of
premature stop codons by C-to-T transitions. Considering that the
C-to-T transition is the most frequent kind of mutation, together
with the 21 bp deletion in G
5SSR426, this Glutamine codon
distribution might contribute to the generation of stop codons at
the periplasmic domain of mucA. Nevertheless, MucA is a protein
which is highly and differentially regulated by proteolysis at its
periplasmic, transmembrane and cytoplasmic domains [31–36].
As an example, it has been recently observed that in a mucoid
isolate, overexpression of truncated mucA alleles at levels of
saturation of the proteolytic enzymes capacities, reverts the
SSRs and Mutagenesis in mucA
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mutated at its periplasmic region, might still retain some degree of
regulatory properties on alginate production or other processes.
Thus, differential selective pressures could exist favoring some
truncated versions of MucA over others. Related to this, it would
be interesting to observe if the addition of a new G:C SSR in the
cytoplasmic or transmembrane domains could determine a biased
mutagnesis towards them.
Summing up, in this work we present another mechanism, SSR-
localized mutagenesis, which might act together with inducible
and stable hypermutability enhancing mutagenesis in mucA. Thus,
these results contribute to the understanding of the mutagenic
process which leads to mucoid conversion in P. aeruginosa, one of
the hallmarks of chronic infection in the airways of CF patients.
Materials and Methods
Bacterial Strains, Plasmids and Culture Media
The bacterial strains and plasmids used in this study are
described in Table 3. P. aeruginosa MPA strain [53] was kindly
provided by Dr Michael Jacobs from the University of Washington
Genome Center (USA). Transposon insertions within the mutS
gene were confirmed by PCR analysis following the provider’s
instructions, and the resulting hypermutable phenotype was
confirmed by the rifampin resistance test (see below). To prepare
inocula, bacteria were routinely cultured on LB (1% NaCl, 1% soy
peptone and 0.5% yeast extract) agar plates from frozen stocks and
subcultured in LB liquid medium overnight at 37uC with shaking
at 250 r.p.m.
AB minimal medium [20] was used to grow continuous cultured
biofilms. Mucoid maintenance agar (MMA) plates were used to
score for mucoid colonies [54]. Antibiotics were used at the
following concentrations unless otherwise indicated: ampicillin
(Ap), 50 mgm l
21; streptomycin (Sm), 200 mgm l
21; rifampin (Rf),
100 mgm l
21.
Construction of Strains MPA-T1, MPA-T2 and MPA-T3 by
mucA Site Directed Mutagenesis
A set of different mucA alleles were engineered to eliminate G
5-
SSR426 or to contain different SSRs, by changing the specific
Table 3. Bacterial strains, plasmids and oligonucleotides used in this study.
Strains, vectors and primers Description
a Source or Reference
Strains
P. aeruginosa
MPA mutS::ISlacZA/hah-Tc
R, MPAO1 derivative [53]
MPA-T1 Tc
R, MPA carrying a mucAT1 allele This study
MPA-T2 Tc
R, MPA carrying a mucAT2 allele This study
MPA-T3 Tc
R, MPA carrying a mucAT3 allele This study
E. coli
XL1-Blue host strain for DNA manipulation [60]
SY327 lpir Rf
R; recipient to propagate pKNG-101 derivatives [61]
SM10 lpir Recipient for conjugal transfer of pKNG-101 derivatives [61]
Vectors
pGEM-T Easy Ap
R; PCR product cloning vector Promega
pGEM-mucAT1 Ap
R; P. aeruginosa mucAT1 cloned in pGEM-T Easy This study
pGEM-mucAT2 Ap
R; P. aeruginosa mucAT2 cloned in pGEM-T Easy This study
pGEM-mucAT3 Ap
R; P. aeruginosa mucAT3 cloned in pGEM-T Easy This study
pKNG101 Sm
R, suicide delivery plasmid containing sacB gene (Suc
S) [55]
pKNG-mucAT1 Sm
R, Suc
S, pKNG101 carrying mucAT1 This study
pKNG-mucAT2 Sm
R, Suc
S, pKNG101 carrying mucAT2 This study
pKNG-mucAT3 Sm
R, Suc
S, pKNG101 carrying mucAT3 This study
Primers
MucPA-F 59-GAAGCCTGACACAGCGGCAAATGC-39 [21]
MucPA-R 59-CCTCAGCGGTTTTCCAGGCTGGCTGC-39 [21]
MucBamHI-F 59-TATGGATCCTGAAGCAATCGACAAAGCTC-39 This study
MucXbaI-R 59-TTATCTAGAAGCTGGGAGGGATCGAACTT-39 This study
MucT1-F 59-GCGAAGAGCAAGGTGCGCCGCAGG-39 This study
MucT1-R 59-CCTGCGGCGCACCTTGCTCTTCGC-39 This study
MucT2-F 59-GCAAGGTGCCCCCCAGGTGATCACCAACTCCTC-39 This study
MucT2-R 59-CTGGGGGGCACCTTGCTCTTCGCTGTAGCCGG-39 This study
MucT3-F 59-AGCAGGGGGCCCCCCAGGTGATCA-39 This study
MucT3-R 59-TGATCACCTGGGGGGCCCCCTGCT-39 This study
aResistance markers: Tc, tetracycline; Rf, rifampin; Sm, streptomycin; Ap, ampicillin; Suc, sucrose.
doi:10.1371/journal.pone.0008203.t003
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the same amino acid and thus maintaining the primary structure
of MucA intact (Figure 1).
To generate the strain MPA-T1, site directed mutagenesis in
mucA was performed by replacing the endogenous mucA gene with a
fragment containing a mutated version of mucA that lacked G
5-
SSR426 (mucAT1), with codon CAG (Gln142) changed to codon
CAA, and codon GGG (Gly143) changed to codon GGT (Figure 1).
The fragment was generated by PCR overlapping extension as
follow: first, a PCR product was amplified using primers
MucBamHI-F (containing an engineered BamHI site) and
MucT1-R (containing the codon substitutions) with genomic
DNA from MPA as the template. Simultaneously, a second PCR
product was obtained using primers MucT1-F (which overlaps with
MucT1-R) and MucXbaI-R (with an engineered XbaI site). Both
resulting PCR products were gel purified (Qiagen) and ,60 ng of
these products were combined for a second PCR reaction which
began with three cycles in the absence of added primers and was
followed by 30 cycles with the addition of primers MucBamHI-F
and MucXbaI-R. The resulting 1014 bp PCR fragment containing
allele mucAT1 was cloned into pGEM-T Easy (Promega) and then
subcloned into the BamHI-XbaI restriction sites of the suicide
vector pKNG101 [55] in order to generate pKNG-mucAT1.
For the generation of strain MPA-T2, the endogenous mucA was
replaced with the mucAT2 allele. Plasmid pKNG-mucAT2 was
constructed following the same steps as pKNG-mucAT1,e x c e p tt h a t
the allele mucAT2 was designed with the following codon substitutions:
CAG to CAA (Gln142); GGG to GGT (Gly143); GCG to GCC (Ala144);
and, CCG to CCC (Pro145) (Figure 1). The fragment containing allele
mucAT2 was generated with the overlapping primers MucT2-F and
MucT2-R (containing the codon substitutions) and the common
primers MucBamHI-F and MucXbaI-R, as described above.
The generation of MPA-T3 was assessed following the same
previous steps, except that the overlapping primers MucT3-F and
MucT3-R (containing the codon substitutions) were used. In this
case, codon substitutions for the generation of mucAT3 consisted in
GCG to GCC (Ala144) and CCG to CCC (Pro145) (Figure 1).
The resulting pKNG101 derivatives were maintained in E. coli
SY327 lpir before being transferred to E. coli SM10 lpir to
perform biparental mating with P. aeruginosa MPA and to carry out
allelic exchange following standard protocols [56]. Briefly, mating
cells were plated on LB agar plates containing 200 mgm l
21 Sm to
select a single homologous recombination event with 50 mgm l
21
Ap to counterselect the donor E. coli. Then, Sm-resistant P.
aeruginosa transconjugants that showed sucrose sensitivity were
grown overnight in LB medium. Finally, the second recombina-
tion event was selected by plating on LB agar supplemented with
16% sucrose and scoring for Sm-sensitive clones. Allelic exchange
was confirmed by DNA sequencing analysis.
Bacterial Growth in Continuous Cultured Biofilms
Bacteria were grown in continuous-flow culture PVC tubing
(USP class VI) with an inner diameter of 1.6 mm. Briefly, ,10
8
cells from overnight (ON) cultures were resuspended in 1 ml of AB
medium before being injected upstream of the tubing and
incubated for 1 h without flow to allow bacterial attachment to
the substratum. Then, the flow was resumed and biofilms were
constantly irrigated with AB medium at 0.05 ml min
21 for five
days. Mucoid colonies were scored by visual inspection after
plating adequate aliquots of the run-off effluents on MMA agar
plates, before incubating them at 37uC for 48 h and again for five
days at room temperature [21].
All determinations were carried out at least in triplicate for three
independent experiments.
Determination of the Mutation Frequency
Single colonies of each strain were cultured overnight in LB
medium at 37uC for 24 h with shaking at 250 r.p.m. Appropriate
dilutions of the cultures were plated on LB agar plates to determine
the total number of viable cells, or on LB agar supplemented with
100 mgm l
21 Rf to count the number of rifampin-resistant cells,
following incubation overnight at 37uC. Then, the mutation
frequency was determined as the ratio of the number of rifampin–
resistant cells and the number of viable cells. Determinations were
carried out in duplicate for three independent experiments, and the
results were expressed as means with their standard deviations.
Determination of Alginate Production
Bacteria were grown in LB medium supplemented with 2%
glycerol at 37uC for 72 h with shaking at 250 r.p.m. After
incubation, the cultures were centrifuged at 7000 g for 15 min and
the alginate present in the supernatants was precipitated with 3
vols of ethanol at 270uC for 24 h, followed by centrifugation at
18000 g for 15 min. The pellet was resuspended in water and the
alginate was quantified by the carbazole assay [25], using alginate
(Sigma) and glucuronic acid as standards.
PCR Amplification and DNA Direct Sequencing of the
mucA Gene
The primers MucPA-F and MucPA-R used to amplify the coding
region of the mucA gene are described in Table 3. Colony PCR of
the P. aeruginosa MPA, MPA-T1, MPA-T2 and MPA-T3 strains, as
well as of their respective mucoid derivates, was performed as
described previously [21]. The PCR products were extracted from
agarose gels with a Gel purification kit (Fermentas) and subjected to
automated direct DNA sequence analyzes (CRC-DNA Sequencing
Facility, Univ. of Chicago, USA) by using the primers described
above. To identify mutations in the mucA gene, the sequences
obtained from the different mucoid variants were analyzed for
homologies with the mucA (PA0763) sequence annotated in the P.
aeruginosa Genome Project [57], by using the BLAST software [58].
Data Resources and Software
Sequences of the mucA (rseA)g e n ef r o mP. aeruginosa strains PAO1
(PA0763),PA14 (PA14_54420), LESB58 (PALES_45801), PA7
(PSPA7_4756) and from the Pseudomonad species P. fluorescens Pf-5
(PFL_1449), P. putida KT2440 (PP_1428), P. syringae phaseolicola
1448A (PSPPH_3954), P. syringae pv. tomato str. DC3000
(PSPTO_4223), P. stutzeri A1501 (PST_1224), P. entomophila L48
(PSEEN4295), and P. mendocina ymp (Pmen_1468) were downloaded
from the Pseudomonas Genome Database [37] (http://www.pseudomo-
nas.com). Alignments were obtained using the Clustal W software [59].
Statistical Analysis
Statistical analysis of the data was performed with the two-tailed
t-test using the GraphPad Instat software, and with the Z-test
(normal approximation) using the Primer of Biostatistics software.
Differences were considered statistically significant when p,0.05.
Acknowledgments
We are grateful to Dr Carlos Argaran ˜a and Dr Jose ´ Echenique for the
valuable discussion and comments on the manuscript.
Author Contributions
Conceived and designed the experiments: AJM AMS. Performed the
experiments: AJM. Analyzed the data: AJM AMS. Wrote the paper: AJM
AMS.
SSRs and Mutagenesis in mucA
PLoS ONE | www.plosone.org 8 December 2009 | Volume 4 | Issue 12 | e8203References
1. Bla ´zquez J (2003) Hypermutation as a factor contributing to the acquisition of
antimicrobial resistance. Clin Infect Dis 37: 1201–1209.
2. Moxon R, Bayliss C, Hood D (2006) Bacterial contingency loci: the role of
simple sequence DNA repeats in bacterial adaptation. Annu Rev Genet 40:
307–333.
3. van Belkum A, Scherer S, van Alphen L, Verbrugh H (1998) Short-sequence
DNA repeats in prokaryotic genomes. Microbiol Mol Biol Rev 62: 275–293.
4. Bichara M, Wagner J, Lambert IB (2006) Mechanisms of tandem repeat
instability in bacteria. Mutat Res 598: 144–163.
5. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, et al. (2006)
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis
patients. Proc Natl Acad Sci U S A 103: 8487–8492.
6. Mena A, Smith EE, Burns JL, Speert DP, Moskowitz SM, et al. (2008) Genetic
adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is
catalyzed by hypermutation. J Bacteriol 190: 7910–7917.
7. Oliver A, Canto ´n R, Campo P, Baquero F, Bla ´zquez J (2000) High frequency of
hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288:
1251–1254.
8. Mai GT, Seow WK, Pier GB, McCormack JG, Thong YH (1993) Suppression
of lymphocyte and neutrophil functions by Pseudomonas aeruginosa mucoid
exopolysaccharide (alginate): reversal by physicochemical, alginase, and specific
monoclonal antibody treatments. Infect Immun 61: 559–564.
9. Pier GB, Small GJ, Warren HB (1990) Protection against mucoid Pseudomonas
aeruginosa in rodent models of endobronchial infections. Science 249: 537–540.
10. Simpson JA, Smith SE, Dean RT (1989) Scavenging by alginate of free radicals
released by macrophages. Free Radic Biol Med 6: 347–353.
11. Boucher JC, Yu H, Mudd MH, Deretic V (1997) Mucoid Pseudomonas aeruginosa
in cystic fibrosis: characterization of muc mutations in clinical isolates and
analysis of clearance in a mouse model of respiratory infection. Infect Immun 65:
3838–3846.
12. Govan JR, Deretic V (1996) Microbial pathogenesis in cystic fibrosis: mucoid
Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60: 539–574.
13. Ramsey DM, Wozniak DJ (2005) Understanding the control of Pseudomonas
aeruginosa alginate synthesis and the prospects for management of chronic
infections in cystic fibrosis. Mol Microbiol 56: 309–322.
14. Boucher JC, Schurr MJ, Deretic V (2000) Dual regulation of mucoidy in
Pseudomonas aeruginosa and sigma factor antagonism. Mol Microbiol 36: 341–351.
15. Boucher JC, Martinez-Salazar J, Schurr MJ, Mudd MH, Yu H, et al. (1996)
Two distinct loci affecting conversion to mucoidy in Pseudomonas aeruginosa in
cystic fibrosis encode homologs of the serine protease HtrA. J Bacteriol 178:
511–523.
16. Ciofu O, Lee B, Johannesson M, Hermansen NO, Meyer P, et al. (2008)
Investigation of the algT operon sequence in mucoid and non-mucoid
Pseudomonas aeruginosa isolates from 115 Scandinavian patients with cystic fibrosis
and in 88 in vitro non-mucoid revertants. Microbiology 154: 103–113.
17. Martin DW, Schurr MJ, Mudd MH, Deretic V (1993) Differentiation of
Pseudomonas aeruginosa into the alginate-producing form: inactivation of mucB
causes conversion to mucoidy. Mol Microbiol 9: 497–506.
18. Martin DW, Schurr MJ, Mudd MH, Govan JR, Holloway BW, et al. (1993)
Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic
fibrosis patients. Proc Natl Acad Sci U S A 90: 8377–8381.
19. Yoon SS, Coakley R, Lau GW, Lymar SV, Gaston B, et al. (2006) Anaerobic
killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic
fibrosis airway conditions. J Clin Invest 116: 436–446.
20. Mathee K, Ciofu O, Sternberg C, Lindum PW, Campbell JI, et al. (1999)
Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism
for virulence activation in the cystic fibrosis lung. Microbiology 145: 1349–1357.
21. Moyano AJ, Luja ´n AM, Argaran ˜a CE, Smania AM (2007) MutS deficiency and
activity of the error-prone DNA polymerase IV are crucial for determining mucA
as the main target for mucoid conversion in Pseudomonas aeruginosa. Mol Microbiol
64: 547–559.
22. Bragonzi A, Wiehlmann L, Klockgether J, Cramer N, Worlitzsch D, et al. (2006)
Sequence diversity of the mucABD locus in Pseudomonas aeruginosa isolates from
patients with cystic fibrosis. Microbiology 152: 3261–3269.
23. Kuban W, Jonczyk P, Gawel D, Malanowska K, Schaaper RM, et al. (2004)
Role of Escherichia coli DNA polymerase IV in in vivo replication fidelity.
J Bacteriol 186: 4802–4807.
24. Garibyan L, Huang T, Kim M, Wolff E, Nguyen A, et al. (2003) Use of the rpoB
gene to determine the specificity of base substitution mutations on the Escherichia
coli chromosome. DNA Repair (Amst) 2: 593–608.
25. Knutson CA, Jeanes A (1968) A new modification of the carbazole analysis:
application to heteropolysaccharides. Anal Biochem 24: 470–481.
26. Levy DD, Cebula TA (2001) Fidelity of replication of repetitive DNA in mutS
and repair proficient Escherichia coli. Mutat Res 474: 1–14.
27. Schaaper RM, Dunn RL (1987) Spectra of spontaneous mutations in Escherichia
coli strains defective in mismatch correction: the nature of in vivo DNA
replication errors. Proc Natl Acad Sci U S A 84: 6220–6224.
28. Gawel D, Jonczyk P, Bialoskorska M, Schaaper RM, Fijalkowska IJ (2002)
Asymmetry of frameshift mutagenesis during leading and lagging-strand
replication in Escherichia coli. Mutat Res 501: 129–136.
29. Anthony M, Rose B, Pegler MB, Elkins M, Service H, et al. (2002) Genetic
analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic
fibrosis patients. J Clin Microbiol 40: 2772–2778.
30. Mathee K, McPherson CJ, Ohman DE (1997) Posttranslational control of the
algT (algU)-encoded sigma22 for expression of the alginate regulon in Pseudomonas
aeruginosa and localization of its antagonist proteins MucA and MucB (AlgN).
J Bacteriol 179: 3711–3720.
31. Qiu D, Eisinger VM, Head NE, Pier GB, Yu HD (2008) ClpXP proteases
positively regulate alginate overexpression and mucoid conversion in Pseudomonas
aeruginosa. Microbiology 154: 2119–2130.
32. Cezairliyan BO, Sauer RT (2009) Control of Pseudomonas aeruginosa AlgW
protease cleavage of MucA by peptide signals and MucB. Mol Microbiol 372:
368–379.
33. Damron FH, Qiu D, Yu HD (2009) The Pseudomonas aeruginosa sensor kinase
KinB negatively controls alginate production through AlgW-dependent MucA
proteolysis. J Bacteriol 191: 2285–2295.
34. Qiu D, Eisinger VM, Rowen DW, Yu HD (2007) Regulated proteolysis controls
mucoid conversion in Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 104:
8107–8112.
35. Reiling SA, Jansen JA, Henley BJ, Singh S, Chattin C, et al. (2005) Prc protease
promotes mucoidy in mucA mutants of Pseudomonas aeruginosa. Microbiology 151:
2251–2261.
36. Wood LF, Leech AJ, Ohman DE (2006) Cell wall-inhibitory antibiotics activate
the alginate biosynthesis operon in Pseudomonas aeruginosa: Roles of sigma (AlgT)
and the AlgW and Prc proteases. Mol Microbiol 62: 412–426.
37. Winsor GL, Van Rossum T, Lo R, Khaira B, Whiteside MD, et al. (2009)
Pseudomonas Genome Database: facilitating user-friendly, comprehensive com-
parisons of microbial genomes. Nucleic Acids Res 37: D483–488.
38. Govan JR, Fyfe JA, Jarman TR (1981) Isolation of alginate-producing mutants
of Pseudomonas fluorescens, Pseudomonas putida and Pseudomonas mendocina.JG e n
Microbiol 125: 217–220.
39. Schnider-Keel U, Lejbolle KB, Baehler E, Haas D, Keel C (2001) The sigma
factor AlgU (AlgT) controls exopolysaccharide production and tolerance towards
desiccation and osmotic stress in the biocontrol agent Pseudomonas fluorescens
CHA0. Appl Environ Microbiol 67: 5683–5693.
40. Smania AM, Segura I, Pezza RJ, Becerra C, Albesa I, et al. (2004) Emergence of
phenotypic variants upon mismatch repair disruption in Pseudomonas aeruginosa.
Microbiology 150: 1327–1338.
41. Bjedov I, Dasgupta CN, Slade D, Le Blastier S, Selva M, et al. (2007)
Involvement of Escherichia coli DNA polymerase IV in tolerance of cytotoxic
alkylating DNA lesions in vivo. Genetics 176: 1431–1440.
42. Petrosino JF, Pendleton AR, Weiner JH, Rosenberg SM (2002) Chromosomal
system for studying AmpC-mediated beta-lactam resistance mutation in
Escherichia coli. Antimicrob Agents Chemother 46: 1535–1539.
43. Cupples CG, Cabrera M, Cruz C, Miller JH (1990) A set of lacZ mutations in
Escherichia coli that allow rapid detection of specific frameshift mutations.
Genetics 125: 275–280.
44. Cupples CG, Miller JH (1989) A set of lacZ mutations in Escherichia coli that allow
rapid detection of each of the six base substitutions. Proc Natl Acad Sci U S A
86: 5345–5349.
45. Foster PL, Trimarchi JM (1994) Adaptive reversion of a frameshift mutation in
Escherichia coli by simple base deletions in homopolymeric runs. Science 265:
407–409.
46. Rosenberg SM, Longerich S, Gee P, Harris RS (1994) Adaptive mutation by
deletions in small mononucleotide repeats. Science 265: 405–407.
47. Tegova R, Tover A, Tarassova K, Tark M, Kivisaar M (2004) Involvement of
error-prone DNA polymerase IV in stationary-phase mutagenesis in Pseudomonas
putida. J Bacteriol 186: 2735–2744.
48. Yang Z, Lu Z, Wang A (2001) Study of adaptive mutations in Salmonella
typhimurium by using a super-repressing mutant of a trans regulatory gene purR.
Mutat Res 484: 95–102.
49. Sokurenko EV, Hasty DL, Dykhuizen DE (1999) Pathoadaptive mutations: gene
loss and variation in bacterial pathogens. Trends Microbiol 7: 191–195.
50. Bla ´zquez J, Go ´mez-Go ´mez JM, Oliver A, Juan C, Kapur V, et al. (2006) PBP3
inhibition elicits adaptive responses in Pseudomonas aeruginosa. Mol Microbiol 62:
84–99.
51. Sanders LH, Rockel A, Lu H, Wozniak DJ, Sutton MD (2006) Role of
Pseudomonas aeruginosa dinB-encoded DNA polymerase IV in mutagenesis.
J Bacteriol 188: 8573–8585.
52. Kuban W, Banach-Orlowska M, Bialoskorska M, Lipowska A, Schaaper RM,
et al. (2005) Mutator phenotype resulting from DNA polymerase IV
overproduction in Escherichia coli: preferential mutagenesis on the lagging strand.
J Bacteriol 187: 6862–6866.
53. Jacobs MA, Alwood A, Thaipisuttikul I, Spencer D, Haugen E, et al. (2003)
Comprehensive transposon mutant library of Pseudomonas aeruginosa. Proc Natl
Acad Sci U S A 100: 14339–14344.
54. Krieg DP, Bass JA, Mattingly SJ (1986) Aeration selects for mucoid phenotype of
Pseudomonas aeruginosa. J Clin Microbiol 24: 986–990.
55. Kaniga K, Delor I, Cornelis GR (1991) A wide-host-range suicide vector for
improving reverse genetics in gram-negative bacteria: inactivation of the blaA
gene of Yersinia enterocolitica. Gene 109: 137–141.
SSRs and Mutagenesis in mucA
PLoS ONE | www.plosone.org 9 December 2009 | Volume 4 | Issue 12 | e820356. de Lorenzo V, Timmis KN (1994) Analysis and construction of stable
phenotypes in gram-negative bacteria with Tn5- and Tn10-derived minitran-
sposons. Methods Enzymol 235: 386–405.
57. Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, et al. (2000)
Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic
pathogen. Nature 406: 959–964.
58. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, et al. (1997) Gapped
BLAST and PSI-BLAST: a new generation of protein database search
programs. Nucleic Acids Res 25: 3389–3402.
59. Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the
sensitivity of progressive multiple sequence alignment through sequence
weighting, position-specific gap penalties and weight matrix choice. Nucleic
Acids Res 22: 4673–4680.
60. Bullock WO, Ferna ´ndez JM, Short JM (1987) XL1-Blue: A high efficiency
plasmid transforming recA Escherichia coli strain with beta-galactosidase selection.
BioTechniques 5: 376–379.
61. Miller VL, Mekalanos JJ (1988) A novel suicide vector and its use in construction
of insertion mutations: osmoregulation of outer membrane proteins and
virulence determinants in Vibrio cholerae requires toxR. J Bacteriol 170:
2575–2583.
SSRs and Mutagenesis in mucA
PLoS ONE | www.plosone.org 10 December 2009 | Volume 4 | Issue 12 | e8203